November 19, 2024 08:00 AM Eastern Standard Time PHILADELPHIA–(BUSINESS WIRE)–Vitara Biomedical, a privately held company developing breakthrough technology intended to transform neonatal care, today announced the closing of a $50M funding round. The company’s technology…
According to filings with the U.S. Securities and Exchange Commission, Vitara Biomedical is raising up to $49,999,190.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold…
Philadelphia, PA – According to filings with the U.S. Securities and Exchange Commission, Vitara Biomedical is raising $74,993,216.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, James Mcglone…